In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile

Thrombosis and Haemostasis

Volumn 92, Issue 6, 2004, Pages 1296-1302

  Gerotziafas, Grigoris T ^a   Chakroun, Tahar ^a   Samama, Meyer M ^a   Elalamy, Ismail ^a  

^a HÔTEL DIEU   (France)

Author keywords

Enoxaparin; Fondaparinux; Thrombin generation; Thromboelastography; Tissue factor

Indexed keywords

ENOXAPARIN; FONDAPARINUX; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; HEMOSTASIS; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOELASTOGRAPHY;

ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOXAPARIN; HUMANS; KINETICS; POLYSACCHARIDES; THROMBELASTOGRAPHY; THROMBIN; THROMBOEMBOLISM; THROMBOPLASTIN; TIME FACTORS; VENOUS THROMBOSIS;

EID: 10444267279     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH03-11-0694     Document Type: Article

References (31)

1. Samama MM, Gerotziafas GT. Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (Fondaparinux). Thromb Res 2003; 109: 1-11.
2. Bauer KA, Eriksson BI, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345: 1305-10.
3. Eriksson BI, Bauer KA, Lassen MR, et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001; 345: 1298-304
4. Thorevska N, Amoateng-Adjepong Y, Sabahi R, et al. Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin. Chest 2004; 125: 856-63.
5. Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162: 1833-40.
6. Linkins LA, Julian JA, Rischke J, et al. In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation. Thromb Res 2002; 107: 241-4.
7. Bara L, Planes A, Samama MM. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery. Br J Haematol 1999; 104: 230-40.
8. Hartert H. Blutgerinnungessstudien mit der thrombelastographie, einem neuen Untersuchungsverfahren. Klein Wochenchr 1948; 26: 577-83.
9. Marchal G, Leroux ME, Samama MM. Interêt de thrombodynamographie (Thromboelastographie) dans l'étude des syndromes hémorragiques. Pat Biol 1958; 951-53.
10. Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg 1985; 64: 888-96.
11. Tuman KJ, McCarthy RJ, Djuric M, et al. Evaluation of coagulation during cardiopulmonary bypass with heparinase-modified thromboelastographic assay. J Cardiothorac Vasc Anesth 1994; 8: 144-49.
12. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography-guided transfusion algorithm reduces transfusion in complex cardiac surgery. Anesth Analg 1999; 88: 312-19.
13. Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg 2000; 90: 1086-88.
14. Rapaport SI, Rao LV. The tissue factor pathway: how it has become a prima ballerina. Thromb Haemost 1995; 74: 7-17.
15. Giesen PLA, Rauch U, Bohrmann B, et al. Blood borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-15.
16. Depasse F, Gerotziafas G.T, Busson J, et al. Assessment of three chromogenic and one clotting assays for measurment of synthetic pentasaccharide fondaparinux (Arixtra) anti-Xa activity. J Thromb Haemost 2004; 2: 346-8
17. Mallett SV, Cox DJ. Thromboelastography. Br J Anaesth 1992; 69: 307-13
18. Vig S, Chitolie A, Bevan DH, et al. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis 2001; 12: 555-61
19. Rand MD, Lock JB, van't Veer C, et al. Blood clotting in minimally altered whole blood. Blood 1996; 88: 3432-45.
20. Holmes MB, Schneider DJ, Hayes MG, et al. Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy. Circulation 2000; 102: 2051-7.
21. Zambruni A, Thalheimer U, Leandro G, et al. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004; 15: 103-7.
22. Boneu B, Necciari J, Cariou R, et al. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/ORG31540) with high affinity to antithrombin III in man. Thromb Haemost 1995; 74: 1468-73.
23. Donat F, Duret JP, Santoni A, et al. The pharmacokinetics of Fondaparinux sodium in healthy volunteers. Clin Pharmacokinet 2002; 41 Suppl 2: 1-9.
24. Bendetowicz AV, Kai H, Knebel R, et al. The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma - a study in human volunteers. Thromb Haemost 1994; 72: 705-12.
25. Gerotziafas GT, Depasse F, Chakroun T, et al. The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux). XIXth Congress of the International Society on Thrombosis and Haemostasis, 12-18/7/2003, Birmingham, UK. J Thromb Haemost 2003; suppl 1.
26. Gerotziafas GT, Depasse F, Chakroun T, et al. Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma. Blood Coagul Fibrinolysis 2004; 15: 149-56.
27. Sorensen B, Johensen P, Christiansen K, et al. Whole blood coagulation thromboelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-58.
28. Lindahl AK, Abildgaard U, Larsen ML, et al. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation. Thromb Res 1991; 14: 39-48.
29. Zmuda K, Neofotistos D, Ts'ao C-H. Effects of unfractionated heparin, low molecular weight heparin, and danaparoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol 2000; 113: 725-31.
30. Khurana S, Mattson JC, Westley S, et al. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tisuue factor-activated thromboelastography. J Lab Clin Med 1997; 130 : 401-11.
31. Engelmann B, Luther T, Muller I. Intravascular tissue factor pathway - a model for rapid initiation of coagulation within the blood vessel. Thromb Haemost 2003; 89: 3-8.